9.09MMarket Cap-136P/E (TTM)
1.490High1.010Low526.05KVolume1.450Open1.440Pre Close647.74KTurnover11.66%Turnover RatioLossP/E (Static)8.08MShares137.90052wk High-0.77P/B5.08MFloat Cap1.01052wk Low--Dividend TTM4.51MShs Float137.900Historical High--Div YieldTTM33.36%Amplitude1.010Historical Low1.231Avg Price1Lot Size
Calidi Biotherapeutics Stock Forum
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
Calidi Biotherapeutics (NYSE American: CLDI) has been granted U.S. Patent No. 12,036,278 for its SuperNova technology platform. This patent, titled 'Smallpox Vaccine for Cancer Treatment,' covers methods and compositions related to cancer immunotherapy, specifically combining smallpox vaccines with various stem cell types.
The patent strengthens Calidi's...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has entered into a collaboration with SIGA Technologies (Nasdaq: SIGA). This partnership, initiated in the first quarter of 2024, aims to accelerate the development of Calidi’s revolutionary RTNova (CLD-...
No comment yet